stockrow
Friday 6 November 2026
Export CCLD’s income statement to Excel — free account
CareCloud, Inc.
CCLD Healthcare Health Information Services
CareCloud, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $120.5 million, up 8.72% from fiscal 2024.
- Revenue
- +8.56%
- EPS
- +150.0%
- Free cash flow
- −0.44%
- Total debt
- +44,345.3%
Quarter to September 2026, against a year earlier
2.31
0.15
+6.94%
Follow CCLD
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 5 Nov | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
36.50 | 33.18 | 30.29 | 15.69 |
P/S ratio |
0.92 | 1.25 | 0.70 | 0.66 | |
P/FCF ratio |
5.37 | 8.04 | 4.60 | 4.85 | |
P/Operating CF |
12.72 | 42.93 | 12.74 | 15.37 | |
P/B ratio |
1.85 | 2.66 | 5.18 | 3.83 | |
Price to Tangible BV |
12.13 | 14.92 | 0.00 | 0.00 | |
EV/Sales |
0.91 | 1.24 | 0.91 | 0.93 | |
EV/EBITDA |
4.11 | 5.85 | 4.60 | 4.82 | |
EV/Operating CF |
3.82 | 5.67 | 4.37 | 4.89 | |
EV/FCF |
5.32 | 7.96 | 5.96 | 6.84 | |
Quick Ratio |
0.76 | 0.81 | 0.82 | 0.65 | |
Current Ratio |
1.05 | 1.11 | 1.02 | 0.87 | |
Net Debt/EBITDA |
(0.52) | (0.71) | 4.41 | 0.00 | |
Debt/Assets |
0.50% | 0.29% | 40.73% | 0.00% | |
Debt/Equity |
0.01 | 0.00 | 2.20 | 0.00 | |
Asset Turnover |
1.51 | 1.55 | 1.52 | 1.48 | |
Operating CF/Net income |
5.70 | (8.15) | 39.08 | 1.35 | |
Capex/Depreciation |
(0.97) | (0.30) | (0.35) | — | |
Interest Coverage |
222.71 | 17.24 | 2.28 | 3.65 | |
Research and Development Expense of Revenue |
7.39% | 7.73% | 6.88% | 3.12% | |
Selling, General and Administrative Expense of Revenue |
18.17% | 22.10% | 20.92% | 18.55% | |
Intangible Assets out of Total Assets |
0.58 | 0.55 | 0.50 | 0.53 | |
Share Based Compensation of Revenue |
0.43% | 0.20% | 0.20% | 0.19% | |
Graham Net Nets |
(0.02) | (0.01) | (0.47) | (0.42) | |
Graham Number |
1.68 | 1.84 | 0.80 | 1.25 | |
Earnings Yield |
2.74% | 3.01% | 3.30% | 6.37% | |
Free Cash Flow Yield |
18.61% | 12.43% | 21.76% | 20.61% | |
Revenue per Share |
0.91 | 0.74 | 0.75 | 0.79 | |
Operating CF per Share |
0.23 | 0.09 | 0.17 | 0.13 | |
Capex per Share |
(0.08) | (0.03) | (0.03) | 0.00 | |
Free Cash Flow per Share |
0.15 | 0.06 | 0.14 | 0.13 | |
Cash per Share |
0.10 | 0.09 | 0.32 | 0.11 | |
Shareholders Equity per Share |
1.57 | 1.37 | 0.41 | 0.53 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.57 | 1.37 | 0.41 | 0.53 | |
Free Cash Flow |
5.81 | 2.38 | 5.75 | 5.64 | |
Working Capital |
1.32 | 2.63 | 0.70 | (4.24) | |
Capital Expenditures |
(2.87) | (1.23) | (1.32) | — | |
Net Current Asset Value |
(2.35) | (2.30) | (42.26) | (36.08) | |
EV/EBIT |
9.63 | 14.86 | 12.72 | 9.74 | |
Capex to Sales |
0.08 | 0.04 | 0.04 | 0.00 | |
Price to Operating Income |
9.73 | 15.02 | 9.80 | 6.91 | |
| Other line items | |||||
Average Receivables |
13.92 | 14.56 | 13.84 | 15.92 | |
Average Payables |
5.75 | 5.23 | 5.14 | 6.45 | |
Average Inventory |
0.54 | 0.52 | 0.50 | 0.56 | |
Average Assets |
79.61 | 80.14 | 84.55 | 88.84 | |
Average Common Equity |
54.64 | 56.25 | 36.74 | 40.21 |
Columns are period end dates · fundamentals updated 5 Nov 2026